Please login to the form below
Seroquel
This page shows the latest Seroquel news and features for those working in and with pharma, biotech and healthcare.
AZ expects return to growth this year after 2017 decline
to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.
Latest news
-
AZ CEO says company’s renaissance is on track
for cholesterol drug Crestor (rosuvastatin) and antipsychotic Seroquel XR (quetiapine).
-
Patent cliff losses set to cost pharma $65bn by 2019
GlobalData analyst Adam Dion said: “ AZ, CNS segment has been bleeding sales as a result of the company losing its patent on Seroquel (quetiapine), a treatment for bipolar disorder.
-
Abilify Maintena launches in Europe
Zyprexa (olanzapine) and AstraZeneca's Seroquel (quetiapine) - now available generically.
-
Setback for Roche as schizophrenia candidate fails studies
The schizophrenia market has been shrinking in recent years as massively successful antipsychotic medicines such as Lilly's Zyprexa (olanzapine), AstraZeneca/Astellas' Seroquel (quetiapine) and Bristol-Myers Squibb/Otsuka Pharmaceutical's
-
AstraZeneca sales hit by Seroquel generics
AstraZeneca sales hit by Seroquel generics. End of patent exclusivity for antipsychotic among key factors dragging down revenues. ... The end of patent protection for Seroquel (quetiapine) in a number of territories put a large dent in AstraZeneca's
More from news
Approximately 3 fully matching, plus 88 partially matching documents found.
Latest Intelligence
-
Who tops the pharma list?
For example, patents for Seroquel (AstraZeneca - 2011 revenues of $5.8bn), Zyprexa (Eli Lily - $4.6bn) and Concerta (J&J - $1.3bn) had all expired by May 2012.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Random42 Scientific Communication
2003 - Gold. Worldfest - Seroquel: The Clever Molecule. 2000 - Finalist Certificate.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Medical Writer
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Scientific Director
-
Great salary and bebefits
-
Senior Programme Executive
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
Subscribe to our email news alerts
PMHub
Brandcast Health
Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...
Latest intelligence
- No incentive for a cure
- The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
Quick links
Infographics
